Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v3-EN
Language French English
Date Updated 2017-12-22 2017-11-09
Drug Identification Number 02370921 02370921
Brand name TRAJENTA TRAJENTA
Common or Proper name Trajenta Trajenta
Company Name BOEHRINGER INGELHEIM (CANADA) LTD LTEE BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Ingredients LINAGLIPTIN LINAGLIPTIN
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 90's 90's
ATC code A10BH A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-11-10 2017-11-10
Actual start date 2017-11-14
Estimated end date 2017-11-21 2017-11-21
Actual end date 2017-12-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments TRAJENTA 5MG TABLETS 3 X 10 REMAINS AVAILABLE TRAJENTA 5MG TABLETS 3 X 10 REMAINS AVAILABLE
Health Canada comments